Tariq Imam - 03 Feb 2025 Form 3 Insider Report for LISATA THERAPEUTICS, INC. (LSTA)

Role
SVP, Bus Dev, General Counsel
Signature
Tariq Imam
Issuer symbol
LSTA
Transactions as of
03 Feb 2025
Net transactions value
$0
Form type
3
Filing time
05 Feb 2025, 16:02:10 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LSTA Common Stock 24,579 03 Feb 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 14 $53.10 Direct
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 96 $56.85 Direct
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 168 $74.25 Direct
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 480 $49.20 Direct
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 466 $23.85 Direct
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 1,466 $13.76 Direct
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 3,000 $3.00 Direct F2
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 4,000 $3.08 Direct F3
holding LSTA Stock Option (Right to Buy) 03 Feb 2025 Common Stock 5,000 $3.80 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 1, 375 restricted stock awards granted on January 9, 2023 and vesting in four equal annual installments beginning on the grant date, (ii) 4,000 restricted stock awards granted on January 9, 2024 and vesting in four equal annual installments beginning on the grant date, and (iii) 6,750 restricted stock awards granted on January 9, 2025 and vesting in four equal annual installments beginning on the grant date.
F2 This option was granted on January 9, 2023 and vests in four equal annual installments beginning on the grant date.
F3 This option was granted on January 9, 2024 and vests in four equal annual installments beginning on the grant date.
F4 This option was granted on January 9, 2025 and vests in four equal annual installments beginning on the grant date.

Remarks:

Senior Vice President, Business Development & General Counsel Exhibit 24.1 - Power of Attorney